Literature DB >> 23245329

Gain of chromosomal region 20q and loss of 18 discriminates between Lynch syndrome and familial colorectal cancer.

Christina Therkildsen1, Göran Jönsson, Mev Dominguez-Valentin, Anja Nissen, Eva Rambech, Britta Halvarsson, Inge Bernstein, Ke Borg, Mef Nilbert.   

Abstract

Lynch syndrome and familial colorectal cancer type X, FCCTX, represent the two predominant colorectal cancer syndromes. Whereas Lynch syndrome is clinically and genetically well defined, the genetic cause of FCCTX is unknown and genomic differences between Lynch syndrome and FCCTX tumours are largely unknown. We applied array-based comparative genomic hybridisation to 23 colorectal cancers from FCCTX with comparison to 23 Lynch syndrome tumours and to 45 sporadic colorectal cancers. FCCTX tumours showed genomic complexity with frequent gains on chromosomes 20q, 19 and 17 and losses of 18, 8p and 15. Gain of genetic material in two separate regions encompassing, 20q12-13.12 and 20q13.2-13.32, was identified in 65% of the FCCTX tumours. Gain of material on chromosome 20q and loss on chromosome 18 significantly discriminated colorectal cancers associated with FCCTX from Lynch syndrome, which likely signifies different preferred tumourigenic pathways.
Copyright © 2012 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2012        PMID: 23245329     DOI: 10.1016/j.ejca.2012.11.011

Source DB:  PubMed          Journal:  Eur J Cancer        ISSN: 0959-8049            Impact factor:   9.162


  12 in total

Review 1.  Genetic predisposition to colorectal cancer: where we stand and future perspectives.

Authors:  Laura Valle
Journal:  World J Gastroenterol       Date:  2014-08-07       Impact factor: 5.742

2.  Genome-wide linkage analysis and tumoral characterization reveal heterogeneity in familial colorectal cancer type X.

Authors:  E Sánchez-Tomé; B Rivera; J Perea; G Pita; D Rueda; F Mercadillo; A Canal; A Gonzalez-Neira; J Benitez; M Urioste
Journal:  J Gastroenterol       Date:  2014-11-09       Impact factor: 7.527

Review 3.  Familial colorectal cancer type X: genetic profiles and phenotypic features.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Sabrina Da Silva; Mef Nilbert
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

Review 4.  Molecular approach to genetic and epigenetic pathogenesis of early-onset colorectal cancer.

Authors:  Gulcin Tezcan; Berrin Tunca; Secil Ak; Gulsah Cecener; Unal Egeli
Journal:  World J Gastrointest Oncol       Date:  2016-01-15

5.  Identification of a novel large EPCAM-MSH2 duplication, concurrently with LOHs in chromosome 20 and X, in a family with Lynch syndrome.

Authors:  Francesca Pirini; Gianluca Tedaldi; Rita Danesi; Ilaria Cangini; Maria Maddalena Tumedei; Anna Ferrari; Silvia Vitali; Giulia De Maio; Carolina Terragna; Vincenza Solli; Michela Tebaldi; Maurizio Puccetti; Valentina Zampiga; Mila Ravegnani; Paola Ulivi; Fabio Falcini; Giovanni Martinelli; Daniele Calistri
Journal:  Int J Colorectal Dis       Date:  2019-10-26       Impact factor: 2.571

6.  Distinct gene expression signatures in lynch syndrome and familial colorectal cancer type x.

Authors:  Mev Dominguez-Valentin; Christina Therkildsen; Srinivas Veerla; Mats Jönsson; Inge Bernstein; Ake Borg; Mef Nilbert
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

7.  Lithium chloride induces mesenchymal‑to‑epithelial reverting transition in primary colon cancer cell cultures.

Authors:  Valeria Costabile; Francesca Duraturo; Paolo Delrio; Daniela Rega; Ugo Pace; Raffaella Liccardo; Giovanni Battista Rossi; Rita Genesio; Lucio Nitsch; Paola Izzo; Marina De Rosa
Journal:  Int J Oncol       Date:  2015-03-02       Impact factor: 5.650

Review 8.  Hereditary Nonpolyposis Colorectal Cancer and Cancer Syndromes: Recent Basic and Clinical Discoveries.

Authors:  Erbao Chen; Xiaojing Xu; Tianshu Liu
Journal:  J Oncol       Date:  2018-04-23       Impact factor: 4.375

Review 9.  Familial Colorectal Cancer Type X.

Authors:  Diana Bregner Zetner; Marie Luise Bisgaard
Journal:  Curr Genomics       Date:  2017-08       Impact factor: 2.236

10.  The nonreceptor tyrosine kinase SRMS inhibits autophagy and promotes tumor growth by phosphorylating the scaffolding protein FKBP51.

Authors:  Jung Mi Park; Seung Wook Yang; Wei Zhuang; Asim K Bera; Yan Liu; Deepak Gurbani; Sergei J von Hoyningen-Huene; Sadie Miki Sakurada; Haiyun Gan; Shondra M Pruett-Miller; Kenneth D Westover; Malia B Potts
Journal:  PLoS Biol       Date:  2021-06-02       Impact factor: 8.029

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.